Main focus of clinical study |
Number |
Using CB for specific hematological disorders |
22 |
Conditioning regimen |
22 |
Use of cellular therapy (e.g. T-cells) post-CB transplantation |
9 |
Use of expanded CBU |
9 |
Combined use of CB and Haploidentical grafts |
7 |
Use of unlicensed CBUs |
5 |
Direct intra-bone infusion of CB |
4 |
Combined use of two CBU |
3 |
Co-infusion of CBU with accessory cells (MSC/Tregs) |
3 |
Use of growth factors (Eltrombopag) post-UCB transplant |
3 |
UCB vs. Haploidentical transplantation |
2 |
Improved homing of UCB HSC |
2 |
T-cell depletion of CBU |
2 |
Fucosylation of CB HSC |
1 |
Management of GvHD infection post-CB transplantation |
2 |
Total clinical trials |
96 |